Tyra Biosciences, Inc. 公布其2026年第一季度的财务数据,显示公司持有的现金、现金等价物及有价证券总额为3.835亿美元。基于当前运营计划与资金消耗率估算,公司预计现有资金足以支持其运营至2028年下半年。
Tyra Biosciences, Inc. 公布其2026年第一季度的财务数据,显示公司持有的现金、现金等价物及有价证券总额为3.835亿美元。基于当前运营计划与资金消耗率估算,公司预计现有资金足以支持其运营至2028年下半年。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.